Respiratory syncytial virus: an under-recognized healthcare-associated infection
Infection Control & Hospital Epidemiology · 2025
DOI: 10.1017/ice.2025.88 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, 2025. Verfasst von Erin B Gettler und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Cross Infection. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS.
Themen: Nosokomiale Infektionen
Abstract (Originalsprache)
Objective
Prior reports of healthcare-associated respiratory syncytial virus (RSV) have been limited to cases diagnosed after the third day of hospitalization. The omission of other healthcare settings where RSV transmission may occur underestimates the true incidence of healthcare-associated RSV.
Design
Retrospective cross-sectional study.
Setting
United States RSV Hospitalization Surveillance Network (RSV-NET) during 2016–2017 through 2018–2019 seasons. Patients: Laboratory-confirmed RSV-related hospitalizations in an eight-county catchment area in Tennessee.
Methods
Surveillance data from RSV-NET were used to evaluate the population-level burden of healthcare-associated RSV. The incidence of healthcare-associated RSV was determined using the traditional definition (i.e., positive RSV test after hospital day 3) in addition to often under-recognized cases associated with recent post-acute care facility admission or a recent acute care hospitalization for a non-RSV illness in the preceding 7 days.
Results
Among the 900 laboratory-confirmed RSV-related hospitalizations, 41 (4.6%) had traditionally defined healthcare-associated RSV. Including patients with a positive RSV test obtained in the first 3 days of hospitalization and who were either transferred to the hospital directly from a post-acute care facility or who were recently discharged from an acute care facility for a non-RSV illness in the preceding 7 days identified an additional 95 cases (10.6% of all RSV-related hospitalizations).
Conclusions
RSV is an often under-recognized healthcare-associated infection. Capturing other healthcare exposures that may serve as the initial site of viral transmission may provide more comprehensive estimates of the burden of healthcare-associated RSV and inform improved infection prevention strategies and vaccination efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
- Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN, USA.
- Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
- Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
ORCID-Profile: Erin B Gettler, Tiffanie M Markus, William Schaffner, Thomas R Talbot
Förderung
- NCATS NIH HHS
Zitieren
APA
Gettler, E. B., Talbot, H. K., Zhu, Y., Ndi, D., Mitchel, E., Markus, T. M., Schaffner, W., Harris, B., & Talbot, T. R. (2025). Respiratory syncytial virus: an under-recognized healthcare-associated infection. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2025.88
Vancouver
Gettler EB, Talbot HK, Zhu Y, Ndi D, Mitchel E, Markus TM, et al. Respiratory syncytial virus: an under-recognized healthcare-associated infection. Infection Control & Hospital Epidemiology. 2025. doi:10.1017/ice.2025.88
BibTeX
@article{Gettler2025,
author = {Gettler, Erin B and Talbot, H Keipp and Zhu, Yuwei and Ndi, Danielle and Mitchel, Edward and Markus, Tiffanie M and Schaffner, William and Harris, Bryan and Talbot, Thomas R},
title = {Respiratory syncytial virus: an under-recognized healthcare-associated infection},
journal = {Infection Control & Hospital Epidemiology},
year = {2025},
doi = {10.1017/ice.2025.88}
}
EUVIMED